Intestinal absorption and buccal absorption of liquid levothyroxine

[11] Unusual malabsorption of levothyroxine [J]. THYROID, 2000, 10 (01) : 93 - 95

[12] Celiac disease presenting as resistant hypothyroidism [J]. THYROID, 2005, 15 (04) : 386 - 388

[13] Shojaei A H, 1998, J Pharm Pharm Sci, V1, P15

[14] Liquid and softgel levothyroxine use in clinical practice: state of the art [J]. ENDOCRINE, 2016, 54 (01) : 3 - 14

[15] Switching Levothyroxine From the Tablet to the Oral Solution Formulation Corrects the Impaired Absorption of Levothyroxine Induced by Proton-Pump Inhibitors [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (12) : 4481 - 4486

[16] The administration of L-thyroxine as soft gel capsule or liquid solution [J]. EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (07) : 1103 - 1111

[17] TABLET LEVOTHYROXINE (L-T4) MALABSORPTION INDUCED BY PROTON PUMP INHIBITOR: A PROBLEM THAT WAS SOLVED BY SWITCHING TO L-T4 IN SOFT GEL CAPSULE [J]. ENDOCRINE PRACTICE, 2014, 20 (03) : E38 - E41

[18] A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations [J]. ENDOCRINE, 2013, 43 (01) : 154 - 160

[19] Wartofsky L., 2000, WERNER INGBARS THYRO, P843

[20] Pharmacokinetics and Potential Advantages of a New Oral Solution of Levothyroxine vs. other Available Dosage Forms [J]. ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (12): : 631 - 636

[11] Unusual malabsorption of levothyroxine [J]. THYROID, 2000, 10 (01) : 93 - 95

[12] Celiac disease presenting as resistant hypothyroidism [J]. THYROID, 2005, 15 (04) : 386 - 388

[13] Shojaei A H, 1998, J Pharm Pharm Sci, V1, P15

[14] Liquid and softgel levothyroxine use in clinical practice: state of the art [J]. ENDOCRINE, 2016, 54 (01) : 3 - 14

[15] Switching Levothyroxine From the Tablet to the Oral Solution Formulation Corrects the Impaired Absorption of Levothyroxine Induced by Proton-Pump Inhibitors [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (12) : 4481 - 4486

[16] The administration of L-thyroxine as soft gel capsule or liquid solution [J]. EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (07) : 1103 - 1111

[17] TABLET LEVOTHYROXINE (L-T4) MALABSORPTION INDUCED BY PROTON PUMP INHIBITOR: A PROBLEM THAT WAS SOLVED BY SWITCHING TO L-T4 IN SOFT GEL CAPSULE [J]. ENDOCRINE PRACTICE, 2014, 20 (03) : E38 - E41

[18] A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations [J]. ENDOCRINE, 2013, 43 (01) : 154 - 160

[19] Wartofsky L., 2000, WERNER INGBARS THYRO, P843

[20] Pharmacokinetics and Potential Advantages of a New Oral Solution of Levothyroxine vs. other Available Dosage Forms [J]. ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (12): : 631 - 636